Hypertrophic cardiomyopathy (HCM) is usually the result of genetic changes that affect the heart muscle. These changes cause the walls of the heart muscle to become excessively thick, which makes it ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

Human capital management (HCM) is the process an organization uses to recruit, manage, develop or optimize employees to improve workforce productivity. It involves hiring the right employees, aligning ...

Please provide your email address to receive an email when new articles are posted on . NATIONAL HARBOR, Md. — Aficamten was associated with sustained improvement in patient-reported symptom burden ...

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that members of the management team will hold a live ...

This year marks the inaugural ISG Software Research HCM Buyer's Guide, though the firm has a long history of evaluating enterprise technology solutions. HiBob's performance in this report is one of ...

Please provide your email address to receive an email when new articles are posted on . Mavacamten did not improve outcomes vs. placebo at 48 weeks in patients with nonobstructive hypertrophic ...